TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05888454

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrative Group Program
Description: The integrative group program consists of 6 in-person sessions directed by a health coach and occurring every other week, and 6 asynchronous educative sessions during a period of 12 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment for T2DM
Description: Conventional medical treatment for T2DM

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional treatment for T2DM
Description: Conventional medical treatment for T2DM
Study: NCT04906239

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector Spinae Plane Block
Description: A high-frequency ultrasound linear probe, covered with a sterile sheath, will be placed approximately 2 cm to the right or left of the T 4-5 spinous process. After showing the T 4-5 transverse process and the erector spinae muscle on top of it, a 22-gauge, 80 mm insulated quincke type needle will be inserted into the skin at an angle of approximately 30 degrees from cranial to caudal, using the in-plane technique. When the transverse process is touched, the needle will be pulled out and after a negative aspiration test with 0.5 mL of normal saline and after the demonstration of a hypo-echogenic image and hydro dissection, a local anesthetic solution will be applied to the fascia beneath the erector spinae muscle. A 20 mL dose of 0.25% bupivacaine, which has been shown to spread both above and below the T 4-5 level, will be injected.
Study: NCT05059639

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Almond
Description: Consume 2 ounces of almond daily for 8 weeks

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pretzel
Description: Consume comparative amount of pretzel daily for 8 weeks
Study: NCT06681844

Intervention type: OTHER
Intervention: Tooth Shape assessed using an intraoral scanner one after avulsion
Description: * Tooth Shape assessed using an intraoral scanner one after avulsion and stored as StereoLithography (STL) file~* Age, gender, reason of avulsion, type of tooth taken from the database and stored in a google sheet
Study: NCT06680713

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Progressive exercise testing on a cyclo ergometer
Study: NCT06680440

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC30
Description: Tablet, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC30
Description: Tablet, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC30
Description: Tablet, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC30
Description: Tablet, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC30
Description: Tablet, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC30
Description: Tablet, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC30
Description: Tablet, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC30
Description: Tablet, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC30
Description: Tablet, QD

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablets, QD

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablets, QD

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablets, QD

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablets, QD

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablets, QD

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablets, QD

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablets, QD

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablets, QD

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tablets, QD
Study: NCT04791488

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Description: Hyperbaric oxygen therapy protocol

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Description: Hyperbaric oxygen therapy protocol

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diving simulation
Description: Hyperbaric chamber diving simulation protocol
Study: NCT06472271

Intervention type: DRUG
Intervention: Polymyxin e
Description: Increased starting colistin dose

Intervention type: DRUG
Intervention: Polymyxin e
Description: Increased starting colistin dose
Study: NCT05967936

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Injection
Description: evaluation of pain by using two different types of local anesthesia

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Injection
Description: evaluation of pain by using two different types of local anesthesia
Study: NCT06467851

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Suanzaoren Decoction and Huanglian Wenda Decoction
Description: Twice daily. Chinese herbal medicine includes: 25 grams of Suanzaoren, 10 grams of chuanxiong, 30 grams of fushen, 10 grams of Polygala tenuifolia, 10 grams of Pinellia ternata, 12 grams of tangerine peel, 15 grams of Zhuru, 30 grams of forged keel, 30 grams of forged oyster,10 grams of aurantii fructus, 6 grams of coptis chinensis, 30 grams of Albizzia bark.Add or subtract Chinese herbal medicine according to the different clinical manifestations of each patient.
Study: NCT05231044

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KX01 ointment 1%
Description: The experimental drug, KX01 Ointment 1% is used in participants with Clinically typical AK on the face or scalp.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Vehicle Ointment is used in participants with Clinically typical AK on the face or scalp.
Study: NCT05693116

Intervention type: PROCEDURE
Intervention: Rhinectomy
Description: Surgery will be performed according to extension of the tumour, i.e. local resection limited to the vestibule, partial rhinectomy, total rhinectomy, extended total rhinectomy
Study: NCT06539247

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Motor Relearning Program with Electrical Muscle Stimulation (MRA + EMS)
Description: This arm received a 30-minute motor relearning program focused on improving foot drop and gait patterns and Electrical Muscle Stimulation (EMS) for Targeted Activation (10 minutes) with 40 mA (default) adaptive, considering both intensity and duration for safe foot lift during walking.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation Technique with Electrical Muscle Stimulation (PNF + EMS)
Description: This arm received a 30-minute intervention combining Proprioceptive Neuromuscular Facilitation (PNF) techniques and EMS. The program consisted of:~PNF Techniques for Neuromuscular Facilitation (20 minutes) and Electrical Muscle Stimulation (EMS) for Muscle Response Enhancement (10 minutes): Similar to Arm 1, EMS applied to the affected ankle dorsiflexors for 10 minutes with the same parameters.
Study: NCT06131554

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
Description: 1 dose of Menhycia (0.5ml) on Day 0, Intramuscular injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: batch 2 of MCV4
Description: 1 dose of Menhycia (0.5ml) on Day 0, Intramuscular injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: batch 3 of MCV4
Description: 1 dose of Menhycia (0.5ml) on Day 0, Intramuscular injection

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Description: 1 dose of Menactra (0.5ml) on Day 0, Intramuscular injection
Study: NCT05333315

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP1
Description: IP1: 2 softchews 3 times a day before meals with 1-2 glasses of water for eight weeks.~OTHER: Placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP2
Description: IP2: One bag per day mixed in 200 mL of cold water or tea and consumed immediately, on an empty stomach, half an hour before breakfast for eight weeks.~OTHER: Placebo
Study: NCT06468137

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Swedish I-ACE
Description: Rehabilitative programme with focus on communication strategies and problem solving for people with hearing loss.
Study: NCT06038097

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency Pallidotomy
Description: Radiofrequency bilateral simultaneous pallidotomy
Study: NCT06468137

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Clinical visit
Description: Visit in the clinic with focus on audiologic rehabilitation.

Intervention type: OTHER
Group type: OTHER
Intervention: No follow-up
Description: Participants choosing no follow-up.
Study: NCT05021848

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: partnered multicomponent exercises program
Description: aerobic,strength, flexibility and balance exercises and game
Study: NCT05333315

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP3
Description: IP3: One bag per day in the morning, dissolved in a glass of warm water and three capsules per day with a glass of water or tea (one capsule at breakfast, one at lunch and one at dinner) for eight weeks.~OTHER:Placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP4
Description: IP4: Twice a day 20 mL half an hour before breakfast and half an hour before dinner for eight weeks.~OTHER:Placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP5
Description: IP5: Formula 1: One capsule per day at breakfast with a glass of water for eight weeks and Formula 2: Two capsules a day at breakfast and at dinner with a glass of water for eight weeks.~OTHER:Placebo
Study: NCT05367635

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKB315 for injection
Description: SKB315 for injection is an Antibody Drug Conjugates (ADC) drug targeting Claudin18.2. The strength of SKB315 is 200 mg/vial.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKB315 for injection
Description: SKB315 for injection is an Antibody Drug Conjugates (ADC) drug targeting Claudin18.2. The strength of SKB315 is 200 mg/vial.
Study: NCT05427162

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prostacyclin Receptor Agonist
Description: Prostacyclin receptor agonist will be administered.
Study: NCT06076954

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CoolMinds
Description: CoolMinds consists of 11 adolescent sessions and 9 parent sessions to be completed simultaneously during a 14-week treatment period. The main components comprise psychoeducation, cognitive restructuring, exposure therapy, and relapse prevention. The parent program also comprises information on how to handle school absenteeism for parents and teachers or pedagogues. The intervention is mainly transdiagnostic within the anxiety disorders but also includes diagnosis specific modules and content allowing for more personalized treatment. The treatment is delivered via a telephone app but can also be accessed via computer.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CoolMinds
Description: CoolMinds consists of 11 adolescent sessions and 9 parent sessions to be completed simultaneously during a 14-week treatment period. The main components comprise psychoeducation, cognitive restructuring, exposure therapy, and relapse prevention. The parent program also comprises information on how to handle school absenteeism for parents and teachers or pedagogues. The intervention is mainly transdiagnostic within the anxiety disorders but also includes diagnosis specific modules and content allowing for more personalized treatment. The treatment is delivered via a telephone app but can also be accessed via computer.
Study: NCT05928793

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mindfulness practices
Description: Mindfulness, according to Kabat-Zinn, is to pay attention to the present moment in a purposeful way, without judgment. Being conscious involves both attention and awareness. Conscious awareness is an observer in the background of the state of consciousness, constantly observing the inner and outer environment. It is to direct our awareness and attention to our experiences in the present moment in an accepting way with our whole body and thoughts.
Study: NCT05390931

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 6-session motivational interviews
Description: A total of 6 motivational interviews will be held once a month. Motivational interviews will be conducted individually.

Intervention type: OTHER
Group type: OTHER
Intervention: Health education structured according to the health belief model
Description: After the participants enrolled in the study, the patients in the study group will be given a health education structured according to the health belief model at the first interview.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health education structured according to the health belief model
Description: After the participants enrolled in the study, the patients in the study group will be given a health education structured according to the health belief model at the first interview.

Intervention type: OTHER
Group type: OTHER
Intervention: Training booklet prepared by the researchers on healthy lifestyle behavior changes
Description: After the participants enrolled in the study and take health education, a training booklet prepared by the researchers on healthy lifestyle behavior changes will be given to the participants.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training booklet prepared by the researchers on healthy lifestyle behavior changes
Description: After the participants enrolled in the study and take health education, a training booklet prepared by the researchers on healthy lifestyle behavior changes will be given to the participants.

Intervention type: OTHER
Group type: OTHER
Intervention: 6 month follow-up
Description: Follow-ups will be made 3 times in total, on the basis of pre-test, intermediate follow-up test (3 months), and post-test (6 months).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 6 month follow-up
Description: Follow-ups will be made 3 times in total, on the basis of pre-test, intermediate follow-up test (3 months), and post-test (6 months).
Study: NCT05023707

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-FLT3 CAR-T
Description: Single intravenous infusion of anti-FLT3 CAR-T cells
Study: NCT06315023

Intervention type: DEVICE
Intervention: DETOUR System
Description: Percutaneous Transmural Arterial Bypass Therapy using the DETOUR™ System

Intervention type: DEVICE
Intervention: DETOUR System
Description: Percutaneous Transmural Arterial Bypass Therapy using the DETOUR™ System
Study: NCT04879225

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tobacco e-liquids
Description: Marketplace includes tobacco flavored e-liquids

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Menthol and Tobacco e-liquids
Description: Marketplace includes menthol and tobacco flavored e-liquids

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mint, Menthol and Tobacco e-liquids
Description: Marketplace includes mint, menthol and tobacco flavored e-liquids

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: All e-liquid flavors
Description: Marketplace includes fruit, dessert, mint, menthol and tobacco flavored e-liquids
Study: NCT05449769

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eNutriCardio personalised nutrition advice
Description: eNutriCardio is a web-based app that administers an FFQ and delivers PN advice to the user. The advice is generated from their responses in the FFQ and considers their sex so the reports are unique to each participant. This report (referred to as a 'healthy eating report') will also include an interactive component, allowing the participant to reflect on the advice received and set personal healthy eating goals to motivate behaviour change. The messages presented in the report have been developed by the eNutriCardio Team, including a registered dietitian and registered nutritionist, are in line with UK dietary guidelines (primarily the EatWell Guide), and promote a Mediterranean-style diet (in line with NICE guidance). Therefore, the advice builds on the generalised advice given during the usual NHS CR programme.
Study: NCT06357312

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: hip trochanteric nail
Description: hip trochanteric nail with and without distal interlocking screw
Study: NCT06223152

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: parental support
Description: parental support
Study: NCT05706350

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Influenza vaccine
Description: Single dose of the Influenza vaccine Participants have to wait until they are invited to receive the vaccine by the general practitioner; this study does not interfere with national planning of the vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Description: Single dose of the Influenza vaccine Participants have to wait until they are invited to receive the vaccine by the general practitioner; this study does not interfere with national planning of the vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Description: Single dose of the Influenza vaccine Participants have to wait until they are invited to receive the vaccine by the general practitioner; this study does not interfere with national planning of the vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Description: Single dose of the Influenza vaccine Participants have to wait until they are invited to receive the vaccine by the general practitioner; this study does not interfere with national planning of the vaccine
Study: NCT05135819

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cyber School for Grandparents
Description: Educational program for secondary school students to become cyber tutors for their grandparents or for senior citizens, who are interested to learn new digital use and skills.
Study: NCT04773509

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Paravertebral block
Description: Randomly selected patients of the PVB group are performed PVB with 0.2% ropivacaine on both sides.
Study: NCT05250206

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myopia control lens
Description: Evaluation of the efficacy in decreasing myopia progression of the proposed ophthalmic lens prototypes.
Study: NCT04792489

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: zamtocabtagene autoleucel (MB-CART2019.1)
Description: Chimeric antigen receptor (CAR) T cell therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Lymphodepleting chemotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Lymphodepleting chemotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Lymphodepleting chemotherapy
Study: NCT05706350

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Plant stanol soft chews (2g per day)
Description: Participants have to consume 4 soft chews per day containing 0.5g plant stanols each (delivered as plant stanol esters), corresponding to a total plant stanol intake of 2g daily

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Plant stanol soft chews (3g per day)
Description: Participants have to consume 6 soft chews per day containing 0.5g plant stanols each (delivered as plant stanol esters), corresponding to a total plant stanol intake of 3g daily

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Plant stanol soft chews (4g per day)
Description: Participants have to consume 8 soft chews per day containing 0.5g plant stanols each (delivered as plant stanol esters), corresponding to a total plant stanol intake of 4g daily

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control soft chews
Description: Participants have to consume 6 control soft chews per day that does not contain plant stanols
Study: NCT05026801

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin plus hydroxychloroquine
Description: All patients will receive active comparator. One group will receive placebo on D1-3 followed by active comparator D4-9, while the other group will receive active comparator D1-6 followed by placebo D7-9.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Azithromycin plus hydroxychloroquine
Description: All patients will receive active comparator. One group will receive placebo on D1-3 followed by active comparator D4-9, while the other group will receive active comparator D1-6 followed by placebo D7-9.
Study: NCT06419504

Intervention type: OTHER
Intervention: SAP block group
Description: US-guided SAP block is performed approximately 30 minutes before the surgery in patients undergoing breast cancer surgery in a separate regional anesthesia room with standard anesthesia monitoring.

Intervention type: OTHER
Intervention: PECS II block group
Description: US-guided PECS II block is performed approximately 30 minutes before the surgery in patients undergoing breast cancer surgery in a separate regional anesthesia room with standard anesthesia monitoring.

Intervention type: OTHER
Intervention: ESP block group
Description: US-guided ESP block is performed approximately 30 minutes before the surgery in patients undergoing breast cancer surgery in a separate regional anesthesia room with standard anesthesia monitoring.

Intervention type: OTHER
Intervention: Control group
Description: No intervention
Study: NCT04996745

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tablet-based educational intervention
Description: POSNA's Orthokids website and the article on pediatric forearm fracture will be provided on a tablet. The article provided has two separate tabs, labeled Condition and FAQs, that caregivers will be able to read through. Those who speak Spanish will have the Spanish translated version of Orthokids.
Study: NCT05036330

Intervention type: OTHER
Intervention: Clinical Evaluation
Description: Undergo speech and swallow evaluation

Intervention type: PROCEDURE
Intervention: Physical Examination
Description: Undergo examination of TEP and laryngectomy stoma

Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Complete questionnaires

Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaires